JP2019131544A5 - - Google Patents

Download PDF

Info

Publication number
JP2019131544A5
JP2019131544A5 JP2019013745A JP2019013745A JP2019131544A5 JP 2019131544 A5 JP2019131544 A5 JP 2019131544A5 JP 2019013745 A JP2019013745 A JP 2019013745A JP 2019013745 A JP2019013745 A JP 2019013745A JP 2019131544 A5 JP2019131544 A5 JP 2019131544A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
formula
acceptable salt
diabetes
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019013745A
Other languages
English (en)
Japanese (ja)
Other versions
JP7241556B2 (ja
JP2019131544A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019131544A publication Critical patent/JP2019131544A/ja
Publication of JP2019131544A5 publication Critical patent/JP2019131544A5/ja
Priority to JP2023034806A priority Critical patent/JP2023071925A/ja
Application granted granted Critical
Publication of JP7241556B2 publication Critical patent/JP7241556B2/ja
Priority to JP2024094812A priority patent/JP2024116307A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019013745A 2018-02-01 2019-01-30 含窒素複素環アミド化合物及びその医薬用途 Active JP7241556B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023034806A JP2023071925A (ja) 2018-02-01 2023-03-07 含窒素複素環アミド化合物及びその医薬用途
JP2024094812A JP2024116307A (ja) 2018-02-01 2024-06-12 含窒素複素環アミド化合物及びその医薬用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018016328 2018-02-01
JP2018016328 2018-02-01

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023034806A Division JP2023071925A (ja) 2018-02-01 2023-03-07 含窒素複素環アミド化合物及びその医薬用途

Publications (3)

Publication Number Publication Date
JP2019131544A JP2019131544A (ja) 2019-08-08
JP2019131544A5 true JP2019131544A5 (https=) 2022-02-03
JP7241556B2 JP7241556B2 (ja) 2023-03-17

Family

ID=67479787

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019013745A Active JP7241556B2 (ja) 2018-02-01 2019-01-30 含窒素複素環アミド化合物及びその医薬用途
JP2023034806A Ceased JP2023071925A (ja) 2018-02-01 2023-03-07 含窒素複素環アミド化合物及びその医薬用途
JP2024094812A Pending JP2024116307A (ja) 2018-02-01 2024-06-12 含窒素複素環アミド化合物及びその医薬用途

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023034806A Ceased JP2023071925A (ja) 2018-02-01 2023-03-07 含窒素複素環アミド化合物及びその医薬用途
JP2024094812A Pending JP2024116307A (ja) 2018-02-01 2024-06-12 含窒素複素環アミド化合物及びその医薬用途

Country Status (21)

Country Link
US (4) US10800784B2 (https=)
EP (1) EP3747888A4 (https=)
JP (3) JP7241556B2 (https=)
KR (1) KR102725118B1 (https=)
CN (1) CN111655692B (https=)
AR (1) AR114237A1 (https=)
AU (1) AU2019214048B2 (https=)
BR (1) BR112020014177A2 (https=)
CA (1) CA3090219A1 (https=)
CL (1) CL2020002003A1 (https=)
CO (1) CO2020009420A2 (https=)
IL (1) IL276386B2 (https=)
MX (1) MX2020008126A (https=)
MY (1) MY205011A (https=)
PE (1) PE20211273A1 (https=)
PH (1) PH12020500613A1 (https=)
SA (1) SA520412473B1 (https=)
SG (1) SG11202006916SA (https=)
TW (1) TWI803570B (https=)
WO (1) WO2019151274A1 (https=)
ZA (1) ZA202004548B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112638377A (zh) 2018-09-11 2021-04-09 日本烟草产业株式会社 含有吡唑酰胺化合物的慢性肾脏病的治疗或预防剂
CN110407744A (zh) * 2019-08-13 2019-11-05 上海毕得医药科技有限公司 一种1-(4-氨基吡啶-2-基)乙酮的合成方法
HRP20241159T1 (hr) 2020-02-07 2024-12-06 Gasherbrum Bio, Inc. Heterociklički agonisti za glp-1
PL4116301T3 (pl) * 2020-03-04 2026-02-16 Japan Tobacco Inc. Skondensowany związek tricykliczny i jego zastosowanie medyczne
CN116368140A (zh) * 2020-09-10 2023-06-30 加舒布鲁姆生物公司 杂环glp-1激动剂
US20240025924A1 (en) * 2021-03-23 2024-01-25 Shanghai Haiyan Pharmaceutical Technology Co., Ltd. Heterocycle substituted ketone derivative, and composition and medicinal use thereof
AU2022337617A1 (en) 2021-09-01 2024-04-18 Japan Tobacco Inc. Nitrogen-containing tricyclic compound and pharmaceutical use thereof
CN120957993A (zh) 2023-02-16 2025-11-14 加舒布鲁姆生物公司 杂环glp-1激动剂

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943617B2 (en) * 2006-11-27 2011-05-17 Bristol-Myers Squibb Company Heterobicyclic compounds useful as kinase inhibitors
WO2008132162A1 (en) * 2007-04-26 2008-11-06 Boehringer Ingelheim International Gmbh 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments
CA2689930A1 (en) 2007-06-01 2008-12-18 Schering Corporation Gamma secretase modulators
EP2090576A1 (en) * 2008-02-01 2009-08-19 Merz Pharma GmbH & Co.KGaA 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators
AR074797A1 (es) * 2008-10-10 2011-02-16 Japan Tobacco Inc Compuesto de fluoreno , composiciones farmaceuticas , inhibidores de pdhk y pdhk2 , metodos de tratamiento , usos de los mismos y kit comercial
CN103889996B (zh) * 2011-06-27 2016-02-03 阿列科托斯治疗有限公司 选择性糖苷酶抑制剂及其用途
WO2013074388A1 (en) 2011-11-15 2013-05-23 Merck Sharp & Dohme Corp. Substituted cyclopropyl compounds useful as gpr119 agonists
DK2858986T3 (da) 2012-06-12 2019-11-25 Chong Kun Dang Pharmaceutical Corp Piperidinderivater som gpr119-agonister
CN103570725B (zh) 2012-08-01 2017-03-22 中国科学院上海药物研究所 哌嗪并三唑类化合物及其制备方法和用途
BR112015022077A2 (pt) * 2013-03-15 2017-07-18 Japan Tobacco Inc composto de pirazol-amida e usos medicinais do mesmo
US20150025120A1 (en) 2013-07-01 2015-01-22 Japan Tobacco Inc. Pyrazole-alcohol compounds and pharmaceutical use thereof
US20150018403A1 (en) * 2013-07-01 2015-01-15 Japan Tobacco Inc. Fluorene-amide compounds and pharmaceutical use thereof
GB201316823D0 (en) 2013-09-23 2013-11-06 R & D Vernalis Ltd New Chemical Entities
ES2665148T3 (es) 2013-12-17 2018-04-24 Merck Patent Gmbh Derivados de N1-(3,3,3-trifluoro-2-hidroxo-2-metilpropionil)-piperidina como inhibidores de la piruvato deshidrogenasa quinasa
EP3328857B1 (en) 2015-07-31 2019-08-14 Merck Patent GmbH Bicyclic heterocyclic derivatives
US11026936B2 (en) 2016-03-29 2021-06-08 Merck Patent Gmbh Piperidinyl-propanone derivatives
CN109071490B (zh) * 2016-04-28 2021-04-06 默克专利股份公司 哌啶基衍生物
KR20190036549A (ko) * 2016-07-29 2019-04-04 니뽄 다바코 산교 가부시키가이샤 피라졸-아미드 화합물의 제조 방법
WO2018034918A1 (en) * 2016-08-15 2018-02-22 Merck Sharp & Dohme Corp. Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease
AU2017350473A1 (en) 2016-10-28 2019-04-18 H. Lundbeck A/S Combination treatments comprising imidazopyrazinones for the treatment of psychiatric and/or cognitive disorders
WO2018078042A1 (en) 2016-10-28 2018-05-03 H. Lundbeck A/S Combination treatments comprising administration of imidazopyrazinones
PL4116301T3 (pl) * 2020-03-04 2026-02-16 Japan Tobacco Inc. Skondensowany związek tricykliczny i jego zastosowanie medyczne
AU2022337617A1 (en) * 2021-09-01 2024-04-18 Japan Tobacco Inc. Nitrogen-containing tricyclic compound and pharmaceutical use thereof

Similar Documents

Publication Publication Date Title
JP2019131544A5 (https=)
JP2021516240A5 (https=)
JP2019094345A5 (https=)
JP2015524443A5 (https=)
JP2013545791A5 (https=)
JP2023529354A5 (https=)
JP2016500063A5 (https=)
RU98119885A (ru) Фармацевтическая композиция, содержащая соединение, имеющее ангиотензин ii антагонистическую активность
JP2017504640A5 (https=)
JP2019531320A5 (https=)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2016512505A5 (https=)
JP2020502111A5 (https=)
JP2007527919A5 (https=)
JP2010516701A5 (https=)
RU2015144182A (ru) Пиразоламидное соединение и его применения в медицине
RU2009128191A (ru) Замещенные метилфенилкетоны, пригодные для использования в качестве ингибиторов pde4
JP2018534288A5 (https=)
JP2010516702A5 (https=)
RU2018104868A (ru) 2-амино-3-фтор-3-(фторметил)-6-метил-6-фенил-3,4,5,6-тетрагидропиридины в качестве ингибиторов bace1
PH12020500613A1 (en) Nitrogenated heterocyclic amide compound, and use thereof for medical purposes
JP2010516700A5 (https=)
IL320810A (en) Glucagon-like peptide 1 receptor agonists
JP2019528279A5 (https=)
JPWO2021187548A5 (https=)